Table:
begin	end	state
1	14	cytoplasmic
15	37	transmembrane
38	48	non-cytoplasmic
49	67	transmembrane
68	96	cytoplasmic
97	114	transmembrane
115	119	non-cytoplasmic
120	142	transmembrane
143	148	cytoplasmic
149	168	transmembrane
169	173	non-cytoplasmic
174	194	transmembrane
195	200	cytoplasmic
201	221	transmembrane
222	266	non-cytoplasmic
267	284	transmembrane
285	315	cytoplasmic
316	341	transmembrane
342	353	non-cytoplasmic
354	380	transmembrane
381	388	cytoplasmic
389	407	transmembrane
408	427	non-cytoplasmic

Input:
>PfGW456L13_122
MSSTTKKTIDLKRSLVDAILAGLVALIVFGPIVGVVLDGYGFNMETSRVAWIVAIVMAGR
FALSLFLQTPKGLRILEGFETTGSGVHVLPPDYKSRLRWIIPLMIVIAVVFPFFSNSYLL
GVVILGLIYVLLGLGLNIVVGLAGLLDLGYVAFYAIGAYGLALGYQYLGLGFWTVLPLAA
ITAGLAGCILGFPVLRLHGDYLAIVTLGFGEIIRLILNNWLTLTGGPNGMAAPLPTFFGI
EFGKRAKEGGVPFHEFFGIAYNPDVKYYFIYAVLFLVVLAVLHIKHRLTRMPVGRAWEAL
REDEIACRSMGLNHVLVKLSAFTIGASTAGLAGVFFATYQGFVNPTSFTFFESALILAIV
VLGGMGSTIGVVIAAFVLTVAPELLRGFAEYRVLLFGILMVLMMIWRPRGLIRISRTGVT
PRKGVAP

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server